Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 188 clinical trials
Reducing Acute Kidney Injury Occurence by Administering Angiotensin II (AIDED)

The aim of this study is to evaluate whether adding angiotensin II to the standard of care is superior compared to the standard of care alone with respect to kidney damage (personalized approach

angiotensin ii
kidney injury
vasopressor
  • 0 views
  • 26 Jul, 2022
  • 1 location
Angiotensin II and Chronic Inflammation in Persistent Microvascular Dysfunction Following Preeclampsia

Women who develop preeclampsia during pregnancy are more likely to develop cardiovascular disease later in life, even if they are otherwise healthy. The reason why this occurs is unclear but may be related to blood vessel damage and increased inflammation that occurs during the preeclamptic pregnancy and persists postpartum. The …

Accepts healthy volunteers
severe pre-eclampsia
  • 7 views
  • 29 May, 2022
  • 1 location
Angiotensin 1-7 as a Therapy in the Treatment of COVID-19

Phase 2 ,double blind, randomized study of therapy with Angiotensin 1-7 in COVID-19 patients. 120 confirmed SARS-CoV-2 infected patients who exhibit moderate- clinical symptoms including dyspnea

  • 0 views
  • 30 Jan, 2021
  • 1 location
Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF.

(Prospective Comparison of Angiotensin Receptor Blocker-Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure) study showed 20

  • 0 views
  • 15 May, 2021
  • 1 location
Program of Angiotensin-Neprilysin Inhibition in Admitted Patients With Worsening Heart Failure (PREMIER)

The aim of this study is to assess the treatment effect of sacubitril valsartan versus conventional therapy for heart failure (HF) in admitted patients due to exacerbation of HF on the N-terminal fragment of pro-B-type natriuretic peptide (NT-proBNP) concentrations.

congestion
b-type natriuretic peptide
angiotensin
ejection fraction
heart failure
  • 0 views
  • 05 Jan, 2022
  • 1 location
The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans

The primary objective is to examine the impact of the Renin-Angiotensin-Aldosterone System (RAAS) blockade with medications (valsartan) or RAAS and neprilysin inhibition (valsartan/sacubitril

sugars
glucose tolerance test
tolerance test
type 2 diabetes mellitus
sacubitril
  • 336 views
  • 08 Aug, 2022
  • 1 location
Effect of Olmesartan or Amlodipine on Serum Angiotensin(1-7) Levels and Vascular Functions in Patients With Type 2 Diabetes and Hypertension (Ang(1-7))

In this study, we will assess the change of serum ACE-2, angiotensin(1-7), and vascular function after using olmesartan (an ARB), compared to conventional anti-hypertensive drug, amlodipine in

blood pressure diastolic
systolic blood pressure
hypertension
angiotensin
amlodipine
  • 0 views
  • 19 Aug, 2022
  • 1 location
The Effect of Ramipril in Suppressing ST2 Expression in Rheumatic Mitral Stenosis Patients

Objective propose: to investigate the effect of Ramipril in suppressing ST2 (suppression of tumorigenicity 2) in the cardiac mitral valve in patients with Rheumatic Heart Disease. We hypothesized that we hypothesized that ramipril will improve rheumatic mitral valve fibrosis through the downregulation of ST2.

mitral valve replacement
stenosis
tricuspid valve repair
rheumatic heart disease
heart disease
  • 116 views
  • 10 Feb, 2022
  • 1 location
A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy (SPARTAN)

angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) therapy.

immunoglobulin a
nephropathy
proteinuria
enzyme inhibitor
angiotensin
  • 4 views
  • 03 Jun, 2022
  • 1 location
Effect of Fimasartan on Extended RAS and Vascular Functions in Patients With Type 2 Diabetes and Hypertension

In this study, we will assess the change of extended renin-angiotensin system including serum ACE-2 and angiotensin(1-7) levels and subclinical atherosclerosis after using fimasartan (an ARB

blood pressure diastolic
systolic blood pressure
atherosclerosis
fimasartan
angiotensin
  • 0 views
  • 08 Jan, 2022
  • 1 location